Inflammatory biomarkers | Improvement of the CAIDE models’ predictive ability for dementia outcomes | ||
---|---|---|---|
All-cause dementia | Alzheimer’s disease | Vascular dementia | |
4E BP1 | Model 2 | - | - |
Beta_NGF | Model 1+2 | - | - |
CCL23 | Model 1+2 | - | - |
CCL3 | Model 2 | - | - |
CD244 | Model 1+2 | - | Model 1+2 |
CST5 | - | Model 1+2 | - |
CXCL1 | Model 1+2 | - | - |
CXCL5 | Model 1+2 | - | - |
EN-RAGE | Model 1+2 | Model 1+2 | Model 1+2 |
FGF21 | Model 1 | - | - |
IL18 | Model 1+2 | - | Model 1+2 |
IL7 | Model 2 | Model 2 | - |
LAP TGF beta1 | Model 1+2 | Model 1+2 | Model 1+2 |
LIFR | Model 1+2 | - | - |
MCP3 | Model 2 | Model 2 | - |
MMP1 | - | Model 2 | - |
OPG | Model 1+2 | - | - |
OSM | Model 1+2 | - | - |
SCF | Model 2 | - | - |
SIRT2 | Model 2 | - | - |
SLAMF1 | Model 1+2 | - | - |
TNFB | Model 1+2 | - | - |
TRAIL | - | Model 2 | - |
VEGFA | Model 1+2 | - | - |